The Oligonucleotide Synthesis Market Overview 2025 report reveals that the market size has grown significantly over the past few years, with projections indicating further expansion.
The Oligonucleotide Synthesis Global Market Report 2024 reveals that the market size has experienced a significant expansion in recent years. The market size is projected to increase from $10.33 billion in 2024 to $11.94 billion in 2025, reflecting a compound annual growth rate (CAGR) of 15.6%.
The market size for oligonucleotide synthesis is expected to reach $22.29 billion in 2029, growing at a compound annual growth rate (CAGR) of 16.9%.
Download Your Free Sample of the 2025 Oligonucleotide Synthesis Market Report and Uncover Key Trends Now!The key drivers in the oligonucleotide synthesis market are:
• Emergence of diagnostic tools
• Advancements in RNA interference therapies
• Development in regenerative medicine and nanotechnology applications
• Innovations in gene editing, including CRISPR-cas technology and next-generation sequencing.
The oligonucleotide synthesis market covered in this report is segmented –
1) By Type: Custom Oligos, Predesigned Oligos
2) By Product Type: Oligonucleotides, Reagents, Equipment, Services, Purification, Modification
3) By Application: Therapeutic Applications, Research Applications, Diagnostic Applications
The key trends in the oligonucleotide synthesis market are:
• The market is seeing developments in diagnostic tools, RNAi therapies, regenerative medicine, and nanotechnology applications.
• A discernible trend in targeted drug development is taking shape.
• There is a growing innovation in delivery systems and automated synthesis.
• The use of CRISPr-cas technology and next-generation sequencing is becoming increasingly prevalent.
The major players in the oligonucleotide synthesis market are:
• Thermo Fisher Scientific Inc
North America was the largest region in the oligonucleotide synthesis market in 2024